[1] Balogh J,Victor D,Asham EH,et al.Hepatocellular carcinoma: a review.J Hepatocell Carcinoma,2016,3:41-53.
[2] 杨薇,陈敏华,严昆,等.肝细胞癌射频治疗总生存率及无瘤生存率探讨.中国医学影像技术,2006,22:121-124.
[3] 王建华,周康荣.肝癌综合性介入治疗规范化方案(草案).临床放射学杂志,2002,21: 470-500.
[4] Yi PS,Zhang M,Zhao JT,et al.Liver resection for intermediate hepatocellular carcinoma. World J Hepatol,2016,8:607-615.
[5] Hocquelet A,Papadopoulos P,Trillaud H.No-touch multibipolar radiofrequency ablation: the new standard ablative technique for hepatocellular carcinoma 5 cm or smaller. Radiology,2016,281:975-976.
[6] Song MJ,Bae SH,Lee JS,et al.Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.Korean J Intern Med,2016,31:242-252.
[7] 帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗30例原发性大肝癌的疗效评价.介入放射学杂志, 2012,21:322-326.
[8] Yamakado K,Nakatsuka A,Ohmori S,et al.Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vasc Interv Radiol,2002,13:1225-1232.
[9] Liu DS,Hoefnagel SJ,Fisher OM,et al.Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis.Oncotarget,2016,7:83342-83358.
[10] 张素文.血清AFP、CA199和GGT联合检测对原发性肝癌诊断的价值.齐齐哈尔医学院学报,2016,37:2183-2184. |
